Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Central nervous system myeloid cells as drug targets: current status and translational challenges.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Tysabri (natalizumab)
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Spasticity: pathophysiology, evaluation and management.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges.

Pages